Tobi Nagel

Dr. Tobi Nagel is the Founder and President of Phages for Global Health, a non-profit organization that facilitates the application of antibacterial phages to combat antimicrobial resistance in developing countries. Before launching Phages for Global Health, Tobi had 15 years of experience in the pharmaceutical industry (including Novartis, Genentech/Roche and Silver Creek Pharmaceuticals), where she worked with international teams to co-develop products that have been tested in over 80 clinical trials worldwide. She is a founding Editorial Board member of the scientific journal PHAGE, an Advisory Board member of the Phagebiotics Research Foundation, and in 2018 she was named a Moonshot Fellow of the Kravis Lab for Social Impact. She formerly served as an Advisory Panel member for the Phages for Human Applications Group Europe and was a member of the Fulbright Specialist program, focusing on building scientific infrastructure in developing countries. Over the past 10 years, she has been a Scientific Consultant for both Global Strategies for HIV Prevention and CRDF Global, facilitating capacity development and technology transfer in international settings. She previously completed a Postdoctoral Fellowship at the American Hospital in Istanbul, Turkey, partnering with the University of California at San Francisco and Baylor College of Medicine. Tobi holds a Ph.D. in Medical Engineering from the joint Harvard-MIT Division of Health Sciences and Technology and a Bachelor of Science in Chemical Engineering from Stanford University.